FDA Inspection
Dominion Fertility & EndocrinologyDominion Fertility & Endocrinology – FDA Inspection, Dec 6, 2024
Record Details
This FDA Inspection record concerns Dominion Fertility & Endocrinology, with an inspection on December 6, 2024, issued by the Baltimore District Office, covering biologics.
View Company Profile
ID · 7ae6b61b-6b2a-44d0-9c5f-286ec66ad62a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256409
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dominion Fertility & Endocrinology
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 18, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 1, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 25, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 14, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Dominion Fertility & Endocrinology
- FDA Inspection 1195526 - 2023-01-24
- FDA Inspection 1099658 - 2019-07-18
- FDA Inspection 1004633 - 2017-02-01
- FDA Inspection 906087 - 2014-11-25
- FDA Inspection 815120 - 2013-01-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.